参考文献/References:
[1] 智信,陈晓,苏佳灿.绝经后骨质疏松症发病机制研究进展[J].中国骨质疏松杂志,2018,24(11):1510-1513.
[2] 中华医学会骨质疏松和骨矿盐疾病分会.原发性骨质疏松症诊疗指南(2017)[J].中国骨质疏松杂志,2019,25(3):281-309.
[3] 《中国老年骨质疏松症诊疗指南》(2018)工作组.中国老年骨质疏松症诊疗指南(2018)[J].中国骨质疏松杂志,2018,24(12):1541-1567.
[4] 刘晨,李兴勇,姚兴璋,等.绝经后骨质疏松症的流行病学概况及发病机制研究进展[J].中医正骨,2018,30(3):52-55.
[5] 方岩,朱涛.绝经后骨质疏松症的治疗进展[J].中国骨质疏松杂志,2019,25(8):1192-1200.
[6] 孙国平,罗选翔,潘彬.绝经后骨质疏松症的预防和药物联合序贯治疗[J].中国组织工程研究,2020,24(33):5385-5390.
[7] 李绍烁,顾一丹,邵阳,等.Citespace知识图谱可视化分析中医药防治绝经后骨质疏松症[J].中国组织工程研究,2020,24(26):4224-4230.
[8] 毛一凡,张佳锋,陈文亮,等.从“虚瘀致毒”论骨痿骨折[J].中医正骨,2019,31(2):44-45.
[9] 陈智能,谢丽丽,李桂锦,等.姚新苗“治痿独取阳明”在糖尿病性骨质疏松症中应用经验探析[J].中华中医药杂志,2019,34(7):3077-3080.
[10] 史晓林,梁博程,李春雯.从“因虚致瘀”论原发性骨质疏松症病机[J].中国中西医结合杂志,2019,39(1):111-114.
[11] 李春雯,王均华.从虚和瘀论治骨痿[J].中医正骨,2018,30(10):62-63.
[12] 刘震坤,金影,董克勤.董克勤治疗绝经后骨质疏松[J].长春中医药大学学报,2018,34(4):702-704.
[13] 李琦,杨鸫祥,那俊夫,等.从虚从瘀探讨绝经后骨质疏松症疼痛发病机理[J].辽宁中医药大学学报,2019,21(10):162-164.
[14] 张文达,任艳玲.绝经后骨质疏松症病因病机研究概况[J].辽宁中医药大学学报,2019,21(7):101-104.
[15] 石敏,赵继荣,薛旭,等.基于“脾主肉、肾主骨”理论探讨绝经后骨质疏松症的OPG/RANK/RANKL信号调控机制[J].中国骨质疏松杂志,2019,25(9):1336-1339.
[16] 刘淼,廖尖兵,王文譞,等.基于“治痿独取阳明”论治特发性肺纤维化[J].中华中医药学刊,2018,36(6):1414-1416.
[17] 吴克亮,林晓生,肖庆华,等.从“治痿独取阳明”论治脾肾两虚型老年性骨质疏松症[J].中国骨质疏松杂志,2020,26(3):449-453.
[18] 林鹏,金涛,史科学,等.经皮椎体后凸成形术联合补肾活血汤口服治疗老年骨质疏松性椎体压缩骨折肾虚血瘀证[J].中医正骨,2019,31(11):72-74.
[19] 秦臻,任艳玲,史馨钰.绝经后骨质疏松症的中药用药规律研究[J].时珍国医国药,2018,29(10):2531-2534.
[20] 王金锋.益气补肾汤治疗原发性骨质疏松症65例临床观察[J].湖南中医杂志,2020,36(2):46-47.
[21] 谭英华,熊仁青.补脾益肾方对去卵巢骨质疏松症模型大鼠防治作用研究[J].吉林中医药,2016,36(7):709-711.
[22] 王振,张晓刚,宋敏,等.OPG/RANK/RANKL系统与原发性骨质疏松症的关联性及补肾活血法的调节作用研究进展[J].中国骨质疏松杂志,2016,22(12):1601-1605.
[23] 杨依然,史晓林,刘钟,等.Lc-ms法筛选强骨饮对绝经后骨质疏松症患者全血差异蛋白的研究[J].中国骨质疏松杂志,2019,25(12):1676-1679.
[24] 梁博程,李敏,王均华,等.基于系统生物学探讨强骨饮防治原发Ⅰ型骨质疏松症的靶标和作用机制[J].中华全科医学,2019,17(6):909-914.
[25] 赵凡,刘全,吴连国.口服强骨饮联合碳酸钙D3片治疗绝经后骨质疏松症的临床研究[J].中医正骨,2019,31(4):26-30.
[26] 赵稜,汪煌,魏杰,等.自拟强骨饮对绝经后骨质疏松患者血清雌激素水平及骨密度影响的临床观察[J].浙江中医药大学学报,2011,35(4):529-531.
[27] 孔令成,施振宇,姚建亮,等.强骨饮治疗骨质疏松性椎体压缩性骨折的临床研究[J].中国骨质疏松杂志,2016,22(9):1159-1163.
[28] 王博,吴鹏,史晓林.强骨饮对去卵巢骨质疏松大鼠骨显微结构的影响[J].中医正骨,2016,28(7):6-9.
[29] 杨依然,刘钟,王均华,等.强骨饮对CKIP-1过表达成骨细胞的影响研究[J].中国中医骨伤科杂志,2018,26(10):1-5.
[30] 刘钟,杨依然,王均华,等.益气温经方对CKIP-1介导的破骨细胞凋亡的影响[J].中国中医骨伤科杂志,2018,26(8):14-17.
相似文献/References:
[1]李林军.应用膨胀式椎弓根螺钉内固定治疗合并骨质疏松的
胸腰椎退行性疾病[J].中医正骨,2015,27(08):49.
[2]李学朋,朱立国.骨疏康胶囊对去卵巢大鼠骨小梁的影响[J].中医正骨,2015,27(12):12.
LI Xuepeng,ZHU Liguo.Effect of Gushukang Jiaonang(骨疏康胶囊)on bone trabecula in the ovariectomized rats[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2015,27(09):12.
[3]陈冠军,陈扬,庄汝杰.可灌注骨水泥椎弓根螺钉系统
在老年腰椎疾患手术中的应用[J].中医正骨,2015,27(02):40.
[4]王丹辉,贲越,韩梅.林蛙油治疗绝经后骨质疏松症的临床研究[J].中医正骨,2014,26(01):27.
Wang Danhui*,Ben Yue,Han Mei..Clinical study of Rana temporaria oil in the treatment of postmenopausal osteoporosis[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2014,26(09):27.
[5]黄建华,黄建武,李慧辉,等.加味左归丸对绝经后骨质疏松症肝肾不足证
患者骨密度的影响[J].中医正骨,2013,25(11):19.
Huang Jianhua*,Huang Jianwu,Li Huihui,et al.Effect of JIAWEI ZUOGUI pill on bone mineral density in postmenopausal osteoporosis patients with deficiency of liver and kidney[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2013,25(09):19.
[6]项旻,杨虹,林爱菊,等.绝经后2型糖尿病患者骨质疏松与血微量元素的关系研究[J].中医正骨,2013,25(12):20.
Xiang Min*,Yang Hong,Lin Aiju,et al.Clinical study on the relationship between osteoporosis and serum trace elements levels in postmenopausal women with type 2 diabetes[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2013,25(09):20.
[7]史晓林,李春雯,张志强.弱阳离子磁珠分离技术和基质辅助激光解吸电离飞行时间质谱技术在原发性Ⅰ型骨质疏松症血清标志蛋白筛选中的应用[J].中医正骨,2014,26(03):5.
Shi Xiaolin*,Li Chunwen,Zhang Zhiqiang..Application of magnetic beads based weak cation exchange separation technology and matrix-assisted laser desorption-ionization time of flight mass spectrometry technology in screening serum protein markers of primary type-Ⅰ osteoporosis[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2014,26(09):5.
[8]李明,徐明雄,冯左基,等.自拟壮骨方治疗绝经后骨质疏松症的疗效及作用机制研究[J].中医正骨,2014,26(09):21.
Li Ming*,Xu Mingxiong,Feng Zuoji,et al.Study on the curative effect and mechanism of action of self-made ZHUANGGU decoction in treatment of postmenopausal osteoporosis[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2014,26(09):21.
[9]陈俊杰,李晴晴,夏瑢.脂代谢及血清内脂素水平与绝经后骨质疏松症的
相关性研究[J].中医正骨,2012,24(04):16.
CHEN Jun-jie*,LI Qing-qing,XIA Rong.*.Study on the correlations between the levels of lipid metabolism and serum visfatin and postmenopausal osteoporosis[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2012,24(09):16.
[10]许超,肖鲁伟,吴承亮.绝经后女性骨质疏松症辨证分型与抑郁焦虑的关系研究[J].中医正骨,2011,23(12):3.
XU Chao*,XIAO Lu-wei,WU Cheng-liang.*.Study on the relationship between the syndrome differ classification and the depression and anxiety for the postmenopausal women with osteoporosis[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2011,23(09):3.
[11]韩艳,温利平,刘娜,等.补肾活血方对去卵巢大鼠骨代谢及骨密度的影响[J].中医正骨,2015,27(12):7.
HAN Yan,WEN Liping,LIU Na,et al.Effect of Bushen Huoxue Fang(补肾活血方)on bone metabolism and bone mineral density in the ovariectomized rats[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2015,27(09):7.
[12]欧国峰,刘鑫,董博,等.绝经后骨质疏松症的免疫学研究进展[J].中医正骨,2016,28(08):70.
[13]施振宇,刘钟,陈文亮,等.中医综合疗法防治绝经后骨量减少的多中心临床研究[J].中医正骨,2017,29(04):1.
SHI Zhenyu,LIU Zhong,CHEN Wenliang,et al.A multicenter clinical study of complex therapy of traditional Chinese medicine for prevention and treatment of postmenopausal osteopenia[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2017,29(09):1.
[14]梁文娜,李西海,李灿东.血清microRNA与绝经后骨质疏松症肾虚证的关系[J].中医正骨,2017,29(10):53.
[15]梁文娜,李西海,胡柳,等.二至丸抑制绝经后骨质疏松大鼠骨代谢紊乱的作用机制研究[J].中医正骨,2017,29(11):1.
LIANG Wenna,LI Xihai,HU Liu,et al.Study on mechanism of action of Erzhi Wan(二至丸)in inhibiting bone metabolism disorder in rats with postmenopausal osteoporosis[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2017,29(09):1.
[16]刘晨,李兴勇,姚兴璋,等.绝经后骨质疏松症的流行病学概况及发病机制研究进展[J].中医正骨,2018,30(03):52.
[17]杨依然,刘钟,毛一凡,等.酪蛋白激酶-2相互作用蛋白1基于磷脂酰肌醇3-激酶/蛋白激酶B/哺乳动物雷帕霉素靶蛋白通路参与绝经后骨质疏松症发生发展过程中细胞自噬的机制[J].中医正骨,2018,30(04):59.
[18]曹俊青,郑剑南,张麟.右归丸联合阿仑膦酸钠口服治疗绝经后骨质疏松症肾阳虚证的临床研究[J].中医正骨,2018,30(05):20.
CAO Junqing,ZHENG Jiannan,ZHANG Lin.A clinical study of oral application of Yougui Wan(右归丸)and alendronate sodium for treatment of postmenopausal osteoporosis with kidney-yang deficiency syndrome[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2018,30(09):20.
[19]李中万,徐绍俊,杨广钢,等.健肾方联合碳酸钙D3咀嚼片(Ⅱ)
治疗绝经后骨质疏松症肾阳虚证[J].中医正骨,2018,30(08):11.
LI Zhongwan,XU Shaojun,YANG Guanggang,et al.Oral application of Jianshen Fang(健肾方)and calcium carbonate and Vitamin D3 chewable tablets(Ⅱ)for treatment of postmenopausal osteoporosis with kidney-yang deficiency syndrome[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2018,30(09):11.
[20]赵凡,刘全,吴连国.口服强骨饮联合碳酸钙D3片治疗绝经后骨质疏松症的临床研究[J].中医正骨,2019,31(04):26.
ZHAO Fan,LIU Quan,WU Lianguo.Oral applications of Qianggu Yin(强骨饮)and calcium carbonate and Vitamin D3 tablets for treatment of postmenopausal osteoporosis:a clinical study[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2019,31(09):26.